Management of Moderate and Severe Forms of Psoriasis in Children: New Opportunities of Genetically Engineered Biologic Drugs

• প্রধান লেখক: Leyla S. Namazova-Baranova (লেখক), Andrey L. Bakulev (লেখক), Nikolay N. Murachkin (লেখক), Lyudmila N. Nam (লেখক), Roman A. Ivanov (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: "Paediatrician" Publishers LLC, 2021-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

The article shows the key role of IL-17 in the psoriasis pathogenesis and the opportunities of its management via monoclonal antibodies product secukinumab. The review of international randomized trials on clinical efficacy and safety of genetically engineered biologic drug secukinumab in children a...